Literature DB >> 23540296

Acyl-CoA thioesterase 8 is a specific protein related to nodal metastasis and prognosis of lung adenocarcinoma.

Woon Yong Jung1, Young Hye Kim, Young Joon Ryu, Baek-Hui Kim, Bong Kyung Shin, Aeree Kim, Han Kyeom Kim.   

Abstract

Metastasis is a major cause of cancer recurrence or death. This study attempted to quantitatively identify different proteins in metastatic lung adenocarcinoma. The N/T quotient [number of metastatic lymph nodes (n)/tumor diameter (cm)] was used to select samples with an extreme metastatic phenotype. Among the six fresh frozen lung adenocarcinoma specimens, the three showing the highest N/T quotient represented the metastatic group, and others with the greatest tumor diameters without metastasis represented the non-metastatic group. After 2-dimensional electrophoresis, the significantly different protein spots were selected by image analysis and analyzed with MALDI-TOF mass spectrometry. Acyl-CoA thioesterase 8 isoform c (ACOT8) was one of most overexpressed proteins in the metastatic group, and it was validated by Western blot and immunohistochemical staining on 108 paraffin-embedded tumor samples. High ACOT8 expression was correlated with lymph node metastasis (p=0.002), recurrence (p=0.034), predominant histologic subtypes (p=0.007), and higher stage (p=0.005). In multivariate analysis, high ACOT8 expression was significantly associated with increased risks of lymph node metastasis (p=0.009) and cancer-related death (p=0.030), independent of clinical factors. ACOT8 may be a candidate prognostic biomarker and therapeutic target of lung adenocarcinoma.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23540296     DOI: 10.1016/j.prp.2013.02.008

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Development and cross-validation of prognostic models to assess the treatment effect of cisplatin/pemetrexed chemotherapy in lung adenocarcinoma patients.

Authors:  Wenjun Mou; Zhaoqi Liu; Yuan Luo; Meng Zou; Chao Ren; Chunyan Zhang; Xinyu Wen; Yong Wang; Yaping Tian
Journal:  Med Oncol       Date:  2014-08-14       Impact factor: 3.064

2.  Overexpression and proliferation dependence of acyl-CoA thioesterase 11 and 13 in lung adenocarcinoma.

Authors:  Jen-Yu Hung; Shyh-Ren Chiang; Kuan-Ting Liu; Ming-Ju Tsai; Ming-Shyan Huang; Jiunn-Min Shieh; Meng-Chi Yen; Ya-Ling Hsu
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

Review 3.  Deactivating Fatty Acids: Acyl-CoA Thioesterase-Mediated Control of Lipid Metabolism.

Authors:  Veronika Tillander; Stefan E H Alexson; David E Cohen
Journal:  Trends Endocrinol Metab       Date:  2017-04-03       Impact factor: 12.015

4.  ACOT11 promotes cell proliferation, migration and invasion in lung adenocarcinoma.

Authors:  Chaoyang Liang; Xiaowei Wang; Zhenrong Zhang; Fei Xiao; Hongxiang Feng; Qianli Ma; Jingjing Huang; Guangliang Qiang; Dingrong Zhong; Deruo Liu
Journal:  Transl Lung Cancer Res       Date:  2020-10

5.  Acyl-CoA Thioesterase 8 and 11 as Novel Biomarkers for Clear Cell Renal Cell Carcinoma.

Authors:  Chao-Liang Xu; Lei Chen; Deng Li; Fei-Teng Chen; Ming-Lei Sha; Yi Shao
Journal:  Front Genet       Date:  2020-12-10       Impact factor: 4.599

Review 6.  Roles of ferroptosis in urologic malignancies.

Authors:  Shankun Zhao; Peng Li; Weizhou Wu; Qinzhang Wang; Biao Qian; Xin Li; Maolei Shen
Journal:  Cancer Cell Int       Date:  2021-12-18       Impact factor: 5.722

7.  Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.

Authors:  Ehsan Gharib; Parinaz Nasrinasrabadi; Mohammad Reza Zali
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.